Latest filing published 13 Jan 2026 for LISATA THERAPEUTICS, INC., €1,921.
Insider track record
James Nisco: trading record in brief
All filings by James Nisco on record concern Lisata Therapeutics, Inc. The record holds 12 filings, for trades running from 1 October 2024 to 9 January 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 13 January 2026, reports a share grant of €3,601 in Lisata Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Nisco
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,137 shares@ US$1.975.3% of flowCommon StockSEC:0002020260-26-000003:3
- 2,131 shares@ US$1.979.9% of flowCommon StockSEC:0002020260-26-000003:1
- 781 shares@ US$1.973.6% of flowCommon StockSEC:0002020260-26-000003:4
- 15,000 shares0Common StockSEC:0002020260-26-000003:0
- 781 shares@ US$3.807.9% of flowCommon StockSEC:0002020260-25-000002:3
- 2,131 shares@ US$3.8021.5% of flowCommon StockSEC:0002020260-25-000002:1
- 1,137 shares@ US$3.8011.5% of flowCommon StockSEC:0002020260-25-000002:2
- 416 shares@ US$3.734.1% of flowCommon StockSEC:0002020260-25-000002:4
- 15,000 shares0Common StockSEC:0002020260-25-000002:0
- 1,701 shares@ US$2.9312.3% of flowCommon StockSEC:0002020260-24-000002:1
- 3,300 shares@ US$2.93100.0% of flowCommon StockSEC:0002020260-24-000002:0
11 of 11 declarations
